216 related articles for article (PubMed ID: 24719246)
1. Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy.
Akcay A; Salcioglu Z; Oztarhan K; Tugcu D; Aydogan G; Ayaz NA; Bornaun H; Sen HS; Akici F; Akdana B
Int J Hematol; 2014 Jun; 99(6):706-13. PubMed ID: 24719246
[TBL] [Abstract][Full Text] [Related]
2. The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.
Chaosuwannakit N; Makarawate P; Wanitpongpun C
Tomography; 2021 Apr; 7(2):130-138. PubMed ID: 33919601
[No Abstract] [Full Text] [Related]
3. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
[TBL] [Abstract][Full Text] [Related]
4. Long-term chelation therapy with deferasirox: effects on cardiac iron overload measured by T2* MRI.
Ruffo GB; Borsellino Z; Cuccia L; Marocco MR; Gagliardotto F; Tarantino R
Clin Drug Investig; 2010; 30(4):267-73. PubMed ID: 20225910
[TBL] [Abstract][Full Text] [Related]
5. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
El Beshlawy A; El Tagui M; Hamdy M; El Ghamrawy M; Azim KA; Salem D; Said F; Samir A; St Pierre T; Pennell DJ
Ann Hematol; 2014 Mar; 93(3):375-9. PubMed ID: 23949317
[TBL] [Abstract][Full Text] [Related]
7. Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.
Wahidiyat PA; Wijaya E; Soedjatmiko S; Timan IS; Berdoukas V; Yosia M
Blood Cells Mol Dis; 2019 Jul; 77():67-71. PubMed ID: 30978615
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
[TBL] [Abstract][Full Text] [Related]
9. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
10. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
Ha SY; Mok AS; Chu WC; Raskalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
Hemoglobin; 2009; 33(5):323-31. PubMed ID: 19814678
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion-dependent thalassemia: A randomized double-blind placebo-controlled trial.
Gupta V; Kumar I; Raj V; Aggarwal P; Agrawal V
Pediatr Blood Cancer; 2022 Jun; 69(6):e29564. PubMed ID: 35092347
[TBL] [Abstract][Full Text] [Related]
12. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
Said Othman KM; Elshazly SA; Heiba NM
Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.
Karakas Z; Yilmaz Y; Bayramoglu Z; Karaman S; Aydogdu S; Karagenc AO; Tugcu D; Dursun M
Radiol Med; 2018 Aug; 123(8):572-576. PubMed ID: 29663188
[TBL] [Abstract][Full Text] [Related]
14. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.
Bayraktaroğlu S; Aydinok Y; Yildiz D; Uluer H; Savaş R; Alper H
Diagn Interv Radiol; 2011 Dec; 17(4):346-51. PubMed ID: 21647857
[TBL] [Abstract][Full Text] [Related]
17. Cardiac iron measurement and iron chelation therapy in patients with β thalassaemia major: experience from Taiwan.
Lu MY; Peng SS; Chang HH; Yang YL; Chen CA; Jou ST; Lin DT; Lin KH
Transfus Med; 2013 Apr; 23(2):100-7. PubMed ID: 23448138
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of deferasirox for reducing total body and cardiac iron in thalassemia.
Merchant R; Ahmed J; Krishnan P; Jankharia B
Indian Pediatr; 2012 Apr; 49(4):281-5. PubMed ID: 21992861
[TBL] [Abstract][Full Text] [Related]
19. Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload.
Pennell DJ; Porter JB; Cappellini MD; Chan LL; El-Beshlawy A; Aydinok Y; Ibrahim H; Li CK; Viprakasit V; Elalfy MS; Kattamis A; Smith G; Habr D; Domokos G; Roubert B; Taher A
Haematologica; 2011 Jan; 96(1):48-54. PubMed ID: 21071497
[TBL] [Abstract][Full Text] [Related]
20. MRI monitoring of myocardial iron overload: use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia.
Quatre A; Jacquier A; Petit P; Giorgi R; Thuret I
Diagn Interv Imaging; 2014 Nov; 95(11):1065-9. PubMed ID: 25001363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
